Patent · US Active

Therapeutic compositions comprising rilpivirine HCL and tenofovir disoproxil fumarate

US10857102B2 · kind B2 · utility

0Cited by

0References

5Claims

0Family size

Assignees

Gilead Sciences, Inc. · US
Janssen Sciences Ireland UC · IE

Inventors

Reza Oliyai · Burlingame, US
Lauren Wiser · San Francisco, US
Mark M. Menning · San Francisco, US

Key dates

Filing date	Nov 18, 2011
Grant date	Dec 8, 2020
Priority date	—
Expiry date	Jan 14, 2033

Classification

Technology area (CPC A)Human Necessities
CPC primaryA61P31/18
WIPO fieldPharmaceuticals
WIPO sectorChemistry

Abstract

The invention provides multilayer tablets that contain rilpivirine hydrochloride, emtricitabine, and tenofivir disoproxil fumarate. The tablets are useful for the treatment of HIV.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.